Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LRRC15 |
| Upstream (Parents) |
|---|
| (<<) PRRX1 → LRRC15 |
| (<<) MMP2 → LRRC15 |
| (<<) CTSK → LRRC15 |
| (<<) GLT8D2 → LRRC15 |
| Downstream (Children) |
|---|
| LRRC15 → APOD (>>) |
| LRRC15 → C1QTNF3///AMACR (>>) |
| LRRC15 → DLX5 (>>) |
| LRRC15 → EN1 (>>) |
| LRRC15 → CRABP2 (>>) |
| LRRC15 → CHN1 (>>) |
| LRRC15 → PENK (>>) |
| LRRC15 → ADCY2 (>>) |
| LRRC15 → ENOX1 (>>) |
| LRRC15 → MMP13 (>>) |
| LRRC15 → DIO2 (>>) |
| LRRC15 → EMX2 (>>) |
| LRRC15 → CYTL1 (>>) |
| LRRC15 → MATN3 (>>) |
| LRRC15 → CNR1 (>>) |
| LRRC15 → LPAR1 (>>) |
| LRRC15 → PRRX2 (>>) |
| LRRC15 → TRO (>>) |
